Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Lukasz Szumowski"'
Autor:
Renate B. Schnabel, Isabelle C. Van Gelder, Lukasz Szumowski, Harry J.G.M. Crijns, Günter Breithardt, Sakis Themistoclakis, Karl Wegscheider, Stephan Willems, G. André Ng, Axel Brandes, Laurent M. Haegeli, Hein Heidbuchel, Anna Suling, Panos E. Vardas, Nele Gessler, Katrin Borof, A. John Camm, Paulus Kirchhof, Andreas Goette, Lars Eckardt, Josef Kautzner
Publikováno v:
European heart journal
Willems, S, Borof, K, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Gessler, N, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Ng, G A, Schnabel, R B, Suling, A, Szumowski, L, Themistoclakis, S, Vardas, P, van Gelder, I C, Wegscheider, K & Kirchhof, P 2022, ' Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial ', European Heart Journal, vol. 43, no. 12, pp. 1219-1230 . https://doi.org/10.1093/eurheartj/ehab593
European Heart Journal, 43(12), 1219-1230. Oxford University Press
Willems, S, Borof, K, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Gessler, N, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Ng, G A, Schnabel, R B, Suling, A, Szumowski, L, Themistoclakis, S, Vardas, P, van Gelder, I C, Wegscheider, K & Kirchhof, P 2022, ' Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial ', European Heart Journal, vol. 43, no. 12, pp. 1219-1230 . https://doi.org/10.1093/eurheartj/ehab593
European Heart Journal, 43(12), 1219-1230. Oxford University Press
Aims Clinical practice guidelines restrict rhythm control therapy to patients with symptomatic atrial fibrillation (AF). The EAST-AFNET 4 trial demonstrated that early, systematic rhythm control improves clinical outcomes compared to symptom-directed
Autor:
Paweł Derejko, Jacek Kuśnierz, Aleksander Bardyszewski, Dobromiła Dzwonkowska, Magdalena Polańska, Michal Orczykowski, Lukasz Szumowski
Pulmonary vein isolation (PVI) using cryoballoon ablation (CBA) is a well-established method for the treatment of atrial fibrillation (AF). As a rule, cryoenergy delivery is preceded by demonstrating full pulmonary vein (PV) occlusion by injecting co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bea2b274c1f8bf8e88f3c01d3464945
https://doi.org/10.22541/au.167574431.18076649/v1
https://doi.org/10.22541/au.167574431.18076649/v1
Autor:
Karl Wegscheider, Christina Magnussen, Paulus Kirchhof, Anna Suling, Ann-Kathrin Ozga, Isabelle C. Van Gelder, Harry J.G.M. Crijns, Andreas Goette, Günter Breithardt, Karl-Heinz Kuck, Michele Massimo Gulizia, Axel Brandes, Lukasz Szumowski, Andreas Rillig, Arif Elvan, A. John Camm, Hein Heidbuchel, Andre Ng, Laurent M. Haegeli, Lars Eckardt
Publikováno v:
Rillig, A, Magnussen, C, Ozga, A-K, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Gulizia, M, Haegeli, L, Heidbuchel, H, Kuck, K-H, Ng, A, Szumowski, L, van Gelder, I, Wegscheider, K & Kirchhof, P 2021, ' Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure ', Circulation, vol. 144, no. 11, pp. 845-858 . https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Circulation, 144(11), 845-858. LIPPINCOTT WILLIAMS & WILKINS
Circulation
Circulation, 144(11), 845-858. LIPPINCOTT WILLIAMS & WILKINS
Circulation
Supplemental Digital Content is available in the text.
Background: Even on optimal therapy, many patients with heart failure and atrial fibrillation experience cardiovascular complications. Additional treatments are needed to reduce these events
Background: Even on optimal therapy, many patients with heart failure and atrial fibrillation experience cardiovascular complications. Additional treatments are needed to reduce these events
Autor:
Arif Elvan, Isabelle C. Van Gelder, Karl-Heinz Kuck, G. André Ng, Christina Magnussen, Karl Wegscheider, Günter Breithardt, Ann-Kathrin Ozga, Hein Heidbuchel, Lukasz Szumowski, Lars Eckhardt, Paulus Kirchhof, Andreas Rillig, Harry J.G.M. Crijns, Laurent M. Haegeli, A. John Camm, Axel Brandes, Michele Massimo Gulizia
Publikováno v:
Heart Rhythm. 18:1628-1630
Autor:
Michal Orczykowski, Marcin Kowalski, Valay K. Parikh, Piotr Urbanek, Bodalski Robert, Pawel Derejko, Grzegorz Warminski, Andrzej Hasiec, Krzysztof Dubowski, Andrzej Glowniak, Radoslaw Sierpinski, Filip Urbanski, Maria Bilinska, Lukasz Szumowski
Publikováno v:
Circulation. 144
Introduction: Atrial fibrillation (AF) is the most common sustained arrhythmia. Catheter Ablation (CA) is considered as a first-line therapy for AF. The risk of 30-days all-cause mortality associated with CA for AF may be underestimated in clinical t
Autor:
Andreas Goette, Lars Eckardt, Hein Heidbuchel, Günter Breithardt, Anna Suling, Lukasz Szumowski, Laurent M. Haegeli, Isabelle C. Van Gelder, Karl-Heinz Kuck, A. John Camm, Stephan Willems, Paulus Kirchhof, Sakis Themistoclakis, Panos E. Vardas, Arif Elvan, Axel Brandes, Harry J.G.M. Crijns, Karl Wegscheider, Luis Mont, A Andre Ng, Andreas Metzner, Josef Kautzner
Publikováno v:
Europace
EP Europace, 24(4), 552-564. Oxford University Press
Europace, 24(4). Oxford University Press
Metzner, A, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Kuck, K-H, Mont, L, Ng, A A, Szumowski, L, Themistoclakis, S, van Gelder, I C, Vardas, P, Wegscheider, K, Willems, S & Kirchhof, P 2022, ' Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST-AFNET 4 trial ', Europace, vol. 24, no. 4, pp. 552-564 . https://doi.org/10.1093/europace/euab200
EP Europace
EP Europace, 24(4), 552-564. Oxford University Press
Europace, 24(4). Oxford University Press
Metzner, A, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Kuck, K-H, Mont, L, Ng, A A, Szumowski, L, Themistoclakis, S, van Gelder, I C, Vardas, P, Wegscheider, K, Willems, S & Kirchhof, P 2022, ' Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST-AFNET 4 trial ', Europace, vol. 24, no. 4, pp. 552-564 . https://doi.org/10.1093/europace/euab200
EP Europace
Aims Treatment patterns were compared between randomized groups in EAST-AFNET 4 to assess whether differences in anticoagulation, therapy of concomitant diseases, or intensity of care can explain the clinical benefit achieved with early rhythm contro
Autor:
Andreas Metzner, Anna Suling, Axel Brandes, Günter Breithardt, A John Camm, Harry J G M Crijns, Lars Eckardt, Arif Elvan, Andreas Goette, Laurent M Haegeli, Hein Heidbuchel, Josef Kautzner, Karl-Heinz Kuck, Luis Mont, G Andre Ng, Lukasz Szumowski, Sakis Themistoclakis, Isabelle C van Gelder, Panos Vardas, Karl Wegscheider, Stephan Willems, Paulus Kirchhof
Publikováno v:
EP Europace. 24:564-564
Autor:
Krzysztof Kaczmarek, Maria Bilińska, Valay Parikh, Phillipe Akhrass, Adam Gorlo, Marcin Kowalski, Piotr Urbanek, Rina Shah, Lukasz Szumowski, Robert Bodalski, Paweł Derejko, Laurence M. Epstein, Paweł Ptaszyński, Artur Zalewski, Andrzej Głowniak, Michał Orczykowski
Publikováno v:
Heart Rhythm. 18:S412
Autor:
Lukasz Szumowski, Przemyslaw Bierut, Marek Kurzynski, Jerzy S. Witkowski, Anna Jaskólska, Jarosław Marusiak, Katarzyna Kisiel-Sajewicz, Andrzej Wolczowski
Publikováno v:
Computers in Biology and Medicine. 87:311-321
One of the biggest problems of upper limb transplantation is lack of certainty as to whether a patient will be able to control voluntary movements of transplanted hands. Based on findings of the recent research on brain cortex plasticity, a premise c
Autor:
Robert Bodalski, Michał Orczykowski, Maria Bilińska, Joanna Zakrzewska-Koperska, Piotr Urbanek, Lukasz Szumowski, Paweł Derejko
Publikováno v:
Acta Cardiologica. 72:404-409
Objective Only limited clinical and electrophysiological data concerning patients (pts) with multiple accessory pathways (MAP) in comparison to large control groups are available. The aim of our study was to analyse these data from the largest cohort